Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
The global auto sector is under strain as China’s tightened ...
GTI Energy (GTR:AU) has announced Retraction of Lo Herma Scoping ...
Leading gold analysis firm Metals Focus published its annual flagship ...
Our website uses cookies to improve your experience. Learn more about: cookie policy